GARETT MOON: Open Payments
NPI 1710571203 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 17 payments from 11 companies in 2025. Trend: 2023 $295 · 2024 $291 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $56 |
| Viatris Specialty LLC | 2 | $38 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Aucta Pharmaceuticals, Inc. | 2 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
Products named: YUPELRI, NURTEC ODT, TRELEGY ELLIPTA, MOUNJARO, REXULTI, BOTOX, QULIPTA, INGREZZA.
Industry payments across AZ — which companies pay providers there.
